Maria Mirotsou

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

Total Citations

H-Index

About

Maria Mirotsou is a leading researcher in cardiac electrophysiology and biomedical engineering, with a focus on developing high-throughput, scalable technologies to accelerate drug discovery and disease modeling. Her major contributions center on the automation of optical mapping systems, which are essential for measuring key cardiac electrophysiological parameters like action potentials and calcium transients. Her most cited work, a 2023 study on a fully-automated low-cost cardiac monolayer optical mapping robot, has already garnered 3 citations, reflecting its immediate impact in the field. This innovation addresses a critical bottleneck in drug development by enabling reproducible, high-content screening of cardiac tissues, reducing costs and human error. Mirotsou’s research bridges the gap between engineering and biology, offering tools that could transform how cardiac diseases are studied and treated. Her notable achievement lies in democratizing advanced electrophysiological measurement, making it accessible for labs with limited resources. For students and researchers, Mirotsou’s work exemplifies how interdisciplinary approaches can solve pressing challenges in cardiovascular medicine, paving the way for safer and more effective therapies.